1. Home
  2. FINW vs MXCT Comparison

FINW vs MXCT Comparison

Compare FINW & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FinWise Bancorp

FINW

FinWise Bancorp

N/A

Current Price

$13.25

Market Cap

181.3M

Sector

Finance

ML Signal

N/A

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

N/A

Current Price

$1.45

Market Cap

155.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FINW
MXCT
Founded
1999
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
181.3M
155.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
FINW
MXCT
Price
$13.25
$1.45
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
★ $16.00
$4.11
AVG Volume (30 Days)
40.9K
★ 1.4M
Earning Date
10-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 21.51
N/A
EPS
★ 0.35
N/A
Revenue
N/A
★ $33,026,000.00
Revenue This Year
$39.89
N/A
Revenue Next Year
$30.60
$15.53
P/E Ratio
$38.16
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.58
$0.64
52 Week High
$19.86
$1.81

Technical Indicators

Market Signals
Indicator
FINW
MXCT
Relative Strength Index (RSI) 72.20 57.00
Support Level $10.79 $1.02
Resistance Level $14.62 $1.54
Average True Range (ATR) 0.69 0.13
MACD 0.40 0.03
Stochastic Oscillator 86.05 48.67

Price Performance

Historical Comparison
FINW
MXCT

About FINW FinWise Bancorp

FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: